US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology: market research reports

The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine.
In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides. In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.

The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.

The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.

RSS Feeds

Biotechnology market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Global Genomics Market : 2014-2018
7/23/2014 | published by: TechNavio - Infiniti Research Ltd.
... Inc., Life Technologies Corp. and Qiagen NV. Other Prominent Vendors in this market are Affymetrix, Agilent Technologies, BGI,Bio-Rad Laboratories, Biotage, Caliper Life Sciences, Cepheid, Cytocell, Enzo Biochem, Exiqon, GE Healthcare, Genisphere, Genomatix Software, Gen-Probe, Harvard ...  |  read more...
USD 2,500
Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market : 2014-2018
7/23/2014 | published by: TechNavio - Infiniti Research Ltd.
... Nucleotide Polymorphism (SNP) Genotyping and Analysis Market: Affymetrix Inc., Illumina Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Douglas Scientific Llc., Fluidigm Corp., Luminex Corp., PREMIER Biosoft Intl., Promega Corp, Qiagen ...  |  read more...
USD 2,500
Sinovac Biotech Ltd. - Product Pipeline Review - 2014
7/22/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sinovac Biotech Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Pharming Group N.V. (PHARM) - Financial and Strategic SWOT Analysis Review
7/22/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
MultiCell Technologies, Inc. (MCET) - Financial and Strategic SWOT Analysis Review
7/22/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
CombiMatrix Corporation (CBMX) - Financial and Strategic SWOT Analysis Review
7/22/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Taiyen Biotech Co., Ltd - Company Capsule
7/18/2014 | published by: Canadean Ltd
... key facts, major products and services, financial ratios, financial analysis, key employees, company locations and subsidiaries. Summary This report is a crucial resource for industry executives and anyone looking to access key information about Taiyen ...  |  read more...
USD 99
Natural and Organic Foods and Beverages in the U.S., 4th Edition
7/16/2014 | published by: Packaged Facts
... years earlier, with the organic foods sector leaping ahead 12.5% in 2014. Amid this rapid growth, the marketplace is changing rapidly, with new plays by traditional retailers like Kroger, Walmart, and Target, and strengthening competition ...  |  read more...
USD 3,995
Neogenix Oncology, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... for the detection of tumor without destroying healthy cells. NOI’s lead product candidate includes Ensituximab, recognizes a particular epitope of tumor specific antigens from pancreatic or colorectal adenocarcinoma. The company also has two additional preclinical ...  |  read more...
USD 750
The Latest Sales Figures in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... global pharmacuetical companies to progressive biotech companies. The analysis leverages the power of BioSeeker's 1stOncology intelligence which combines company disclosed product sales and detailed drug development information. The results is not only a unique insight ...  |  read more...
USD 4,478
Stratatech Corporation - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... which promotes wound healing by the patient's own cells. The company’s expressgraft is an enhanced tissue that produces various levels of natural wound healing and antimicrobial factors. It offers human tissue substitutes generated with NIKS ...  |  read more...
USD 750
XDx, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... patient outcomes. It commercializes AlloMap molecular expression testing, which aids clinicians in identifying heart transplant recipients with stable graft function. XDx applies genomics and bioinformatics technology to develop molecular diagnostic assays based on gene expression ...  |  read more...
USD 750
Proteins in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... 667 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 190 drugs. Proteins In Oncology Drug Pipeline Update lists ...  |  read more...
USD 6,746
Oxford Biodynamics Limited - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... for detection, monitoring and prognosis of major diseases associated with aberrant gene expression including oncology, inflammatory, metabolic, cardiovascular and neurodegenerative conditions. Oxford Bio’s products under clinical development include OBD 27, OBD 29, OBD 35, OBD ...  |  read more...
USD 750
Cleveland Biolabs, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cleveland Biolabs, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Compugen, Ltd. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Compugen, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
WaferGen Bio:systems, Inc : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' WaferGen Bio-systems, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Cell Therapeutics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cell Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Bayer CropScience AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Bayer MaterialScience AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Bayer MaterialScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Galapagos NV : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Galapagos NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Generex Biotechnology Corporation : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Generex Biotechnology Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
InterMune, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' InterMune, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Intercell AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Intercell AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
< prev 1    3  4  5  6  7  8  9  10